Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
31 05 2021
Historique:
received: 17 02 2021
revised: 30 03 2021
accepted: 31 03 2021
pubmed: 7 4 2021
medline: 4 3 2022
entrez: 6 4 2021
Statut: ppublish

Résumé

Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows into the cytoplasm through membrane tears in dystrophin-deficient myofibers, which leads to muscle contracture and necrosis. Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) takes up cytosolic Ca2+ into the sarcoplasmic reticulum, but its activity is decreased in dystrophic muscle. Here, we show that an allosteric SERCA activator, CDN1163, ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice. The administration of CDN1163 prevented exercise-induced muscular damage and restored mitochondrial function. In addition, treatment with CDN1163 for 7 weeks enhanced muscular strength and reduced muscular degeneration and fibrosis in mdx mice. Our findings provide preclinical proof-of-concept evidence that pharmacological activation of SERCA could be a promising therapeutic strategy for DMD. Moreover, CDN1163 improved muscular strength surprisingly in wild-type mice, which may pave the new way for the treatment of muscular dysfunction.

Identifiants

pubmed: 33822956
pii: 6210386
doi: 10.1093/hmg/ddab100
pmc: PMC8170845
doi:

Substances chimiques

Dmd protein, mouse 0
Dystrophin 0
Sarcoplasmic Reticulum Calcium-Transporting ATPases EC 3.6.3.8
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1006-1019

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Bioorg Med Chem. 2017 Jan 1;25(1):53-57
pubmed: 27776889
Genes Dev. 1998 Aug 15;12(16):2499-509
pubmed: 9716403
Br J Pharmacol. 2008 Oct;155(4):574-84
pubmed: 18641676
Hum Mol Genet. 2009 Jul 15;18(14):2584-98
pubmed: 19401296
Brain. 2014 Oct;137(Pt 10):2670-9
pubmed: 25062695
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):264-9
pubmed: 17182743
Neuromuscul Disord. 2014 Jun;24(6):482-91
pubmed: 24780148
Dev Biol. 1994 Apr;162(2):486-98
pubmed: 8150209
J Neurol Sci. 1995 Apr;129(2):97-105
pubmed: 7608742
Hum Gene Ther. 2010 Dec;21(12):1735-9
pubmed: 20540606
Curr Opin Neurol. 2013 Oct;26(5):577-84
pubmed: 23995279
J Physiol. 2001 Sep 1;535(Pt 2):591-600
pubmed: 11533147
Lancet Neurol. 2018 Mar;17(3):251-267
pubmed: 29395989
Nature. 2012 Apr 04;484(7394):394-8
pubmed: 22495301
Hum Mol Genet. 2013 Jan 1;22(1):153-67
pubmed: 23049075
Skelet Muscle. 2020 Feb 1;10(1):3
pubmed: 32007101
J Vis Exp. 2013 Jan 31;(71):e50036
pubmed: 23407283
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
J Biomol Screen. 2014 Feb;19(2):215-22
pubmed: 24436077
J Muscle Res Cell Motil. 2013 Dec;34(5-6):349-56
pubmed: 23748997
J Transl Med. 2011 Aug 11;9:132
pubmed: 21834967
J Biomol Screen. 2013 Jan;18(1):97-107
pubmed: 22923787
Biochem Biophys Res Commun. 2003 May 9;304(3):445-54
pubmed: 12729578
J Biol Chem. 2002 Nov 22;277(47):45323-30
pubmed: 12235157
Nat Med. 2009 Mar;15(3):325-30
pubmed: 19198614
Bioorg Med Chem Lett. 2018 May 15;28(9):1591-1594
pubmed: 29602679
J Clin Invest. 2011 Mar;121(3):1044-52
pubmed: 21285509
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
pubmed: 17318226
J Biol Chem. 2016 Mar 4;291(10):5185-98
pubmed: 26702054
Cell. 1987 Dec 24;51(6):919-28
pubmed: 3319190
J Neurol Sci. 1990 Dec;100(1-2):9-13
pubmed: 2089145
FASEB J. 2008 Aug;22(8):2990-3000
pubmed: 18417546
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell Rep. 2018 Sep 25;24(13):3593-3606.e10
pubmed: 30257218
J Cell Biol. 2003 Jun 9;161(5):957-67
pubmed: 12796481
Genes Dev. 2000 Sep 1;14(17):2123-33
pubmed: 10970876
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(8):798-821
pubmed: 20948175
Neuromuscul Disord. 2012 May;22(5):427-34
pubmed: 22206641
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375170
Sci Rep. 2017 Aug 2;7(1):7168
pubmed: 28769032
Am J Physiol Cell Physiol. 2015 May 1;308(9):C699-709
pubmed: 25652448
Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H144-53
pubmed: 20971771
Physiol Rep. 2019 Feb;7(3):e13998
pubmed: 30756520
Redox Biol. 2019 Jan;20:68-74
pubmed: 30296699
JCI Insight. 2019 Apr 9;5:
pubmed: 30964448
Cell Death Differ. 2017 Feb;24(2):330-342
pubmed: 27834955
Physiol Rev. 2016 Jan;96(1):253-305
pubmed: 26676145
Nat Med. 2013 Jan;19(1):101-6
pubmed: 23202294
Nat Med. 2008 Apr;14(4):442-7
pubmed: 18345011
Nature. 1988 Jun 30;333(6176):861-3
pubmed: 3290683
J Biochem. 1995 Nov;118(5):959-64
pubmed: 8749313
Acta Myol. 2012 Oct;31(2):121-5
pubmed: 23097603
PLoS One. 2012;7(11):e49862
pubmed: 23185465
Physiol Genomics. 2008 Sep 17;35(1):106-15
pubmed: 18628337
Muscle Nerve. 1994 Jan;17(1):2-15
pubmed: 8264699
Am J Physiol. 1987 Aug;253(2 Pt 1):C296-300
pubmed: 2956887
Muscle Nerve. 2007 Apr;35(4):430-42
pubmed: 17286271

Auteurs

Ken'ichiro Nogami (K)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yusuke Maruyama (Y)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.

Fusako Sakai-Takemura (F)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Norio Motohashi (N)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Ahmed Elhussieny (A)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Neurology, Faculty of Medicine, Minia University, Minia, Egypt.

Michihiro Imamura (M)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Satoshi Miyashita (S)

Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Megumu Ogawa (M)

Department of Neuromuscular Research, National Institute of Neuroscience, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

Satoru Noguchi (S)

Department of Neuromuscular Research, National Institute of Neuroscience, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Clinical Development, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

Yuki Tamura (Y)

Graduate School of Health and Sport Science, Nippon Sport Science University, Tokyo, Japan.
Research Institute for Sport Science, Nippon Sport Science University, Tokyo, Japan.

Jun-Ichi Kira (JI)

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yoshitsugu Aoki (Y)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Shin'ichi Takeda (S)

National Center of Neurology and Psychiatry, Tokyo, Japan.

Yuko Miyagoe-Suzuki (Y)

Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH